T cell vaccination in secondary progressive multiple sclerosis (Q40873787)

24 September 2017

T cell vaccination in secondary progressive multiple sclerosis (English)

1 reference

secondary progressive multiple sclerosis

24 September 2017

0 references

multiple sclerosis

0 references

author name string

Correale J

1

1 reference

24 September 2017

Lund B

2

1 reference

24 September 2017

McMillan M

3

1 reference

24 September 2017

Ko DY

4

1 reference

24 September 2017

McCarthy K

5

1 reference

24 September 2017

Weiner LP

6

1 reference

24 September 2017

1 July 2000

1 reference

Journal of Neuroimmunology

24 September 2017

1 reference

24 September 2017

107

1 reference

24 September 2017

2

1 reference

24 September 2017

130-139

1 reference

Suppressor cell function in multiple sclerosis: Correlation with clinical disease activity

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Isolation of myelin basic protein-reactive T-cell lines from normal human blood

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

IL-10 fails to abrogate experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Physiological basis of T-cell vaccination against autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

The cognitive paradigm and the immunological homunculus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Human CD8+ TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

T cell vaccination in multiple sclerosis: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Lines of T Lymphocytes Induce or Vaccinate Against Autoimmune Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Vaccination against experimental autoimmune diseases using T lymphocytes treated with hydrostatic pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Induction of an anti-vaccine response by T cell vaccination in non-human primates and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Fas and FasL in the homeostatic regulation of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Immunological aspects of demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Immunopathogenesis of multiple sclerosis: the role of T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Myelination in rat brain: method of myelin isolation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Interleukin-10 prevents experimental allergic encephalomyelitis in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Effects of inoculation with attenuated autologous T cells in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

Human CD8+ T lymphocyte clones specific for T cell receptor V beta families expressed on autologous CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900235-6

7 January 2021

10.1016/S0165-5728(00)00235-6

Identifiers

DOI

1 reference

24 September 2017

1 reference